290 related articles for article (PubMed ID: 28505045)
1. Resistant hypertension in 2017.
Hans S; Reilly JP
Curr Opin Cardiol; 2017 Jul; 32(4):389-396. PubMed ID: 28505045
[TBL] [Abstract][Full Text] [Related]
2. Renal denervation for resistant hypertension and beyond.
Laffin LJ; Bakris GL
Adv Chronic Kidney Dis; 2015 Mar; 22(2):133-9. PubMed ID: 25704350
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
Voora R; Hinderliter AL
Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
[TBL] [Abstract][Full Text] [Related]
4. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
Schlaich MP
Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871
[TBL] [Abstract][Full Text] [Related]
5. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
Kjeldsen SE; Os I; Mahfoud F
EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
[No Abstract] [Full Text] [Related]
6. Renal denervation for treatment-resistant hypertension.
Mafeld S; Vasdev N; Haslam P
Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):245-58. PubMed ID: 23132232
[TBL] [Abstract][Full Text] [Related]
7. Challenging anatomy, how to treat or not to treat?
Zeller T; Rastan A; Macharzina R; Noory E
EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
[TBL] [Abstract][Full Text] [Related]
8. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
[TBL] [Abstract][Full Text] [Related]
9. Renal sympathetic denervation in the treatment of resistant hypertension.
Sánchez-Álvarez C; González-Vélez M; Stilp E; Ward C; Mena-Hurtado C
Yale J Biol Med; 2014 Dec; 87(4):527-35. PubMed ID: 25506285
[TBL] [Abstract][Full Text] [Related]
10. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
Esler MD; Böhm M; Sievert H; Rump CL; Schmieder RE; Krum H; Mahfoud F; Schlaich MP
Eur Heart J; 2014 Jul; 35(26):1752-9. PubMed ID: 24898552
[TBL] [Abstract][Full Text] [Related]
11. Recent Developments and Controversies in the Treatment of Resistant Hypertension.
Kühl C; Frey N; Frank D
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):178-86. PubMed ID: 27008634
[TBL] [Abstract][Full Text] [Related]
12. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?
Briasoulis A; Bakris G
Can J Cardiol; 2015 May; 31(5):642-8. PubMed ID: 25828371
[TBL] [Abstract][Full Text] [Related]
13. Renal denervation in the treatment of resistant arterial hypertension.
Lambert T; Schützenberger W; Steinwender C
Wien Med Wochenschr; 2014 Dec; 164(23-24):515-8. PubMed ID: 25394989
[TBL] [Abstract][Full Text] [Related]
14. Renal Denervation in the Management of Resistant Hypertension: A Comprehensive Review of Literature.
Salehin S; Karnkowska B; Hamza I; Malik H; Syeda D; Hasan SM; Rangasetty U; Gilani S; Jneid H; Raja M
Curr Probl Cardiol; 2024 Feb; 49(2):102137. PubMed ID: 37863457
[TBL] [Abstract][Full Text] [Related]
15. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
[TBL] [Abstract][Full Text] [Related]
16. Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
Epstein M; de Marchena E
J Am Soc Hypertens; 2015 Feb; 9(2):140-9. PubMed ID: 25649995
[TBL] [Abstract][Full Text] [Related]
17. Resistant hypertension: is renal denervation the current treatment of choice?
Reddi AS
Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
[TBL] [Abstract][Full Text] [Related]
18. Renal denervation: a plea for wisdom.
Lantelme P; Courand PY; Pathak A
Arch Cardiovasc Dis; 2013 Mar; 106(3):121-3. PubMed ID: 23582673
[No Abstract] [Full Text] [Related]
19. [Renal denervation in patients with resistant hypertension: is it still possible to resuscitate?].
Táborský M; Schejbalová M
Vnitr Lek; 2014 Dec; 60(12):1081-5. PubMed ID: 25692837
[TBL] [Abstract][Full Text] [Related]
20. Renal denervation in the treatment of resistant hypertension: Dead, alive or surviving?
Al-Fakhouri A; Efeovbokhan N; Nakhla R; Khouzam RN
Rev Port Cardiol; 2016 Oct; 35(10):531-8. PubMed ID: 27614724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
